Technical Analysis for IFRX - InflaRx N.V.

Grade Last Price % Change Price Change
grade A 38.77 4.39% 1.63
IFRX closed up 4.39 percent on Friday, April 20, 2018, on 87 percent of normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical IFRX trend table...

Date Alert Name Type % Chg
Apr 20 New 52 Week Closing High Bullish 0.00%
Apr 20 New 52 Week High Strength 0.00%
Apr 20 Upper Bollinger Band Walk Strength 0.00%
Apr 20 Wide Bands Range Expansion 0.00%
Apr 20 Above Upper BB Strength 0.00%
Apr 20 Overbought Stochastic Strength 0.00%
Apr 20 Up 3 Days in a Row Strength 0.00%
Apr 20 Up 4 Days in a Row Strength 0.00%
Apr 20 Up 5 Days in a Row Strength 0.00%
Apr 20 Upper Bollinger Band Touch Strength 0.00%

Older signals for IFRX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development.
Is IFRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 39.0
52 Week Low 14.47
Average Volume 58,975
200-Day Moving Average 0.0
50-Day Moving Average 30.0422
20-Day Moving Average 31.6765
10-Day Moving Average 34.301
Average True Range 2.4353
ADX 39.81
+DI 29.89
-DI 7.54
Chandelier Exit (Long, 3 ATRs ) 31.6941
Chandelier Exit (Short, 3 ATRs ) 33.7659
Upper Bollinger Band 38.4879
Lower Bollinger Band 24.8651
Percent B (%b) 1.02
BandWidth 43.006014
MACD Line 2.235
MACD Signal Line 1.4008
MACD Histogram 0.8342
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 41.08
Resistance 3 (R3) 40.90 39.95 40.70
Resistance 2 (R2) 39.95 39.36 40.04 40.57
Resistance 1 (R1) 39.36 39.00 39.66 39.54 40.44
Pivot Point 38.41 38.41 38.56 38.50 38.41
Support 1 (S1) 37.82 37.82 38.12 38.00 37.10
Support 2 (S2) 36.87 37.46 36.96 36.97
Support 3 (S3) 36.28 36.87 36.85
Support 4 (S4) 36.46